Umoja Biopharma
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of UB-VV500 With Rapamycin in Relapsed/Refractory Multiple Myeloma (NCT07735546) | Umoja Biopharma | 2026-10-01 |
| A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies (NCT07735533) | Umoja Biopharma | 2026-08-01 |
| A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies (NCT06528301) | Umoja Biopharma | 2025-03-10 |
Track Umoja Biopharma automatically
Every clearance here is in the API, with alerts when new ones post.